27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
Please see Chart below for more information....By: Orrick, Herrington & Sutcliffe LLP
Read More >
Minority attorneys continue to depart law firms at a higher rate than those in the majority and cont...
Read More >
A federal appeals court just resurrected the salary history ban that will now prevent Philadelphia e...
Read More >
On two fronts, the Human Resources department has an increasingly important role in the privacy and ...
Read More >
On January 27, 2020, the U.S. Federal Trade Commission ("FTC") announced in the Federal Register tha...
Read More >
The U.S. Department of Labor unveiled its final revisions to the Fair Labor Standards Act (“FLSA”)...
Read More >